LAMEA Bone Densitometers Market Analysis (2017-2023)
The LAMEA Bone Densitometers Market would witness market growth of 5% CAGR during the forecast period (2017-2023). A bone density test measures calcium and other minerals in a given bone segment. Weak bones limit the
The LAMEA Bone Densitometers Market would witness market growth of 5% CAGR during the forecast period (2017-2023). A bone density test measures calcium and other minerals in a given bone segment. Weak bones limit the ability to conduct daily activities. Broken bones, particularly major breaks such as hip fractures, can lead to disability and pain that is ongoing. Osteoporosis leads to bone thinning and porous, decreasing bone strength and eventually leading to a risk of breaking bones. As per Osteoporosis Canada, one in five men and one in three women would suffer from osteoporotic fracture at some point in time. Growing prevalence of osteoporosis, Paget's disease, and osteogenesis imperfecta are the major factors that that would contribute to the growth of the bone densitometer market during the forecast period. Osteoporosis is a disorder which is major and can lead to fragile bones which would eventually break over a period of time. The biggest challenge is the disorder does not show any symptoms or discomfort until bones start breaking. BDM is used to predict the risks pertaining to bone fractures in individuals with poor bone density, which would drive the market growth during the forecast period.
Based on Application, the market report segments the market into Central Scan and Peripheral Scan. Technology is further divided into DEXA (Dual Energy X-ray Absorptiometry), Ultrasound, and other technology. The end User covered under the report is Hospitals, Clinics, and Other End User. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the LAMEA Bone Densitometers Market. Key companies profiled in the report include CompuMed, Inc., BeamMed Ltd., Hologic, Inc., GE Healthcare, Lone Oak Medical Technologies LLC, Osteometer MediTech, Inc., CooperSurgical, Inc, Demetech AB, DMS Imaging, and Swissray International Inc.